Date published: 2025-10-28

00800 4573 8000

SCBT Portrait Logo
Seach Input

Inhibiteurs Lefty

Lefty inhibitors belong to a distinct class of chemical compounds known for their pivotal role in regulating embryonic development and cell differentiation. These inhibitors are closely associated with the transforming growth factor-beta (TGF-β) superfamily of signaling molecules. To understand Lefty inhibitors, it's essential to appreciate their role within the intricate process of embryogenesis. During early development, Lefty inhibitors play a fundamental role in establishing the body plan of an organism. They are known for their function in maintaining symmetry and axis formation, a critical step in the early stages of embryonic development. Lefty inhibitors act as antagonists to certain signaling pathways within the TGF-β superfamily, exerting their influence by interfering with the signaling molecules involved. Specifically, they counteract the activity of Nodal, an important TGF-β member, which plays a key role in specifying the left-right axis in vertebrates. By doing so, Lefty inhibitors help ensure that the developing embryo forms with appropriate bilateral symmetry, preventing developmental abnormalities and ensuring the proper organization of vital organs.

Lefty inhibitors can be broadly classified into two isoforms: Lefty-1 and Lefty-2. Both isoforms exhibit similar mechanisms of action, working as negative regulators by binding to Nodal and inhibiting its signaling. This function is crucial for maintaining the balance of the Nodal pathway, preventing excessive or inappropriate signaling that could lead to developmental defects. Lefty inhibitors are a prime example of the delicate checks and balances that govern embryonic development. Their presence ensures the precise orchestration of signaling pathways, guaranteeing that an organism's body plan and symmetry are established correctly during its early stages of development. Understanding the mechanisms of Lefty inhibitors is not only essential for developmental biology but also holds potential implications for various fields of science and medicine, shedding light on the intricacies of cell signaling and differentiation.

VOIR ÉGALEMENT...

Items  1  to  10  of  15 total

Afficher:

Nom du produitCAS #Ref. CatalogueQuantitéPrix HTCITATIONS Classement

BIBF1120

656247-17-5sc-364433
sc-364433A
5 mg
10 mg
$180.00
$315.00
2
(0)

Le nintedanib est un inhibiteur de tyrosine kinase qui cible plusieurs récepteurs, notamment le VEGFR, le FGFR et le PDGFR, inhibant ainsi les voies de l'angiogenèse et de la fibrose.

Imatinib mesylate

220127-57-1sc-202180
sc-202180A
25 mg
100 mg
$44.00
$109.00
61
(1)

L'imatinib inhibe la tyrosine kinase BCR-ABL, empêchant la signalisation aberrante dans la leucémie myéloïde chronique (LMC) et les tumeurs stromales gastro-intestinales (GIST).

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Ce composé inhibe largement la transcription et pourrait réduire l'expression de nombreux gènes, dont LEFTY.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Le sorafénib cible les kinases RAF et VEGFR, perturbant les voies MAPK et VEGF, qui jouent un rôle dans la croissance et la propagation des cellules.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$74.00
$119.00
33
(1)

L'erlotinib inhibe la tyrosine kinase de l'EGFR, bloquant les voies de signalisation en aval impliquées dans la promotion de la croissance et de la division cellulaires.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Un inhibiteur de la traduction des protéines qui pourrait réduire la synthèse des protéines LEFTY.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

Le sunitinib inhibe le VEGFR, le PDGFR et d'autres kinases, interférant avec l'angiogenèse et la prolifération des cellules tumorales. Il est principalement utilisé dans le carcinome rénal.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

Le géfitinib est un inhibiteur de l'EGFR tyrosine kinase, qui stoppe la croissance et la division des cellules en perturbant les voies de signalisation pilotées par l'EGFR.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Le dasatinib cible la protéine BCR-ABL et d'autres kinases, supprimant la prolifération des cellules leucémiques; il est principalement utilisé pour la leucémie myéloïde chronique (LMC).

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

Compte tenu de l'interaction entre les signaux Wnt et TGF-β, des inhibiteurs tels que XAV-939 ou ICG-001 pourraient moduler indirectement l'expression ou l'activité de LEFTY.